Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic myeloid leukemia

C L Sawyers1

  • 1Department of Medicine and Molecular Biology Institute, University of California at Los Angeles, 90095-1678, USA. csawyers@med1.medsch.ucla.edu

The New England Journal of Medicine
|April 29, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America·2007
Same author

Making progress through molecular attacks on cancer.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Research on resistance to cancer drug Gleevec.

Science (New York, N.Y.)·2001
Same author

Chronic myelogenous leukemia.

Hematology. American Society of Hematology. Education Program·2001
Same author

Recent success with the tyrosine kinase inhibitor STI-571--lessons for targeted therapy of cancer.

Current opinion in investigational drugs (London, England : 2000)·2001
Same journal

Ebola at 50 - Lessons for Outbreak Response and Preparedness.

The New England journal of medicine·2026
Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

The New England journal of medicine·2026
Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients. Reply.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
See all related articles